Lyell Immunopharma Inc reports results for the quarter ended in June - Earnings Summary

Lyell Immunopharma

13/08/2021 01:03

* Lyell Immunopharma Inc  LYEL.OQ  reported a quarterly adjusted
loss of 89 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 36 cents per share.
* Revenue was $2.63 million​;  analysts expected $2.25 million. 
* Lyell Immunopharma Inc's reported EPS for the quarter was a
loss of $1.47​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Lyell Immunopharma Inc shares had fallen by 11.3% this
quarter.
* The company reported a quarterly loss of $62.6 million.
* Wall Street's median 12-month price target for Lyell
Immunopharma Inc is $27.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 13 at 12:03 a.m.  ​All
figures in US dollars unless otherwise stated